vaccines

The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic. The

The prediction was the latest suggestion from a major drugmaker that the race to produce a vaccine for the deadly COVID-19 bug could reach a significant milestone in the coming months.

Biotech firm Moderna expects to have about 20 million doses of its experimental coronavirus vaccine ready to ship in the US by the end of the year. The Massachusetts-based drug developer will be

Biotech firm Moderna expects to know by November whether its coronavirus vaccine is effective at warding off the deadly disease, CEO Stephane Bancel said Thursday. Massachusetts-based Moderna says it has enrolled 25,296 people in the late-stage clinical trial of its COVID-19 vaccine that kicked off in July, one of three such studies currently underway in …

Bill Gates says Pfizer has the best chance of seeking emergency approval for a coronavirus vaccine by next month even though he thinks such an aggressive timeline is unlikely. “The only vaccine that if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer,” the billionaire tech tycoon-turned-philanthropist …

Pharmaceutical giant Pfizer will likely know by the end of next month if its coronavirus vaccine is effective, CEO Albert Bourla said. There’s a “more than 60 percent” chance that the drugmaker’s clinical research will produce results by the end of October showing whether or not the shot works, Bourla said in a Sunday TV …

AstraZeneca’s coronavirus vaccine could still be ready this year even though it had to halt a key clinical study after a participant got sick, CEO Pascal Soriot said Thursday. The British pharmaceutical firm should know by the end of 2020 whether the vaccine protects patients from the virus if it’s able to resume the study …

Nine drugmakers pledged Tuesday to make safety their top priority as they race to develop a vaccine for the deadly coronavirus — vowing they would not seek emergency authorization before large-scale Phase 3 clinical trials are completed. The biopharma firms said in a joint statement that they would follow “high ethical standards and sound scientific …

The Trump administration is weighing a fast-tracked process that would allow AstraZeneca’s coronavirus vaccine to be used in the US before November’s presidential election, a new report says. One plan under consideration would see the Food and Drug Administration issue an “emergency use authorization” for the British drugmaker’s vaccine candidate in October, the Financial Times …

Top Beijing officials are promising certain countries, with whom they have strategic partnerships, early access to China’s imminent coronavirus vaccines as they seek to repair their global image following criticism over their failure to contain the initial outbreak of the virus. The countries China is working with to produce vaccines and provide early access include …